COMPOUNDS, COMPOSITIONS, AND METHODS

The present disclosure relates generally to LRRK2 inhibitors, or a pharmaceutically acceptable salt, deuterated analog, prodrug, tautomer, stereoisomer, or mixture of stereoisomers thereof, and methods of making and using thereof.

Saved in:
Bibliographic Details
Main Authors Feng, Jianwen A, Sweeney, Zachary K, de Vicente Fidalgo, Javier, Estrada, Anthony A, Lyssikatos, Joseph P
Format Patent
LanguageEnglish
Published 20.07.2023
Subjects
Online AccessGet full text

Cover

Loading…